A previous notice advised of the application made to the Supreme Court for designation of all New Jersey state court litigation involving the contraceptive NuvaRing as a mass tort and assignment of that litigation for centralized management. That application was submitted pursuant to Rule 4:38A and the Revised Mass Tort Guidelines as promulgated by Directive No. 10-07 and was published for comment. The Court received several comments regarding the application. This notice is to advise that the Supreme Court, after considering the application and all comments received, has designated all pending and future actions arising out of the use of NuvaRing as a mass tort and assigned the litigation to Superior Court Judge Jonathan N. Harris in Bergen County for centralized management. Published with this notice are the Supreme Court’s March 10, 2009 order as well as Judge Harris’s March 12, 2009 Case Management Order. Both orders are also posted in the Mass Tort Information Center in the Judiciary’s Internet Web site, (www.njcourts.com).
Questions concerning this matter may be directed to Michelle V. Perone, Esq., Chief, Civil Court Programs, Administrative Office of the Courts, Hughes Justice Complex, P.O. Box 981, Trenton, New Jersey 08625-0981; telephone (609) 984-5431; email address [email protected].
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
